Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung Cancer.

Arielle Elkrief Meagan Montesion Smruthy S Sivakumar Caryn R Hale Anita S Bowman Ayyuce Begum BektasMartina BradicWenfei KangEric Chan Pooja GogiaKatia Manova-TodorovaDouglas A MataJacklynn V EggerHira RizviNicolas D SocciDaniel W KellyEric RosiekFanli MengGrittney TamNing FanAlexander E Drilon Helena Alexandra Yu Gregory J Riely Natasha Rekhtman Álvaro Quintanal-Villalonga Snjezana Dogan Umeshkumar K Bhanot Mithat Gönen Brian R Loomis Matthew D Hellmann Adam J Schoenfeld Marc Ladanyi Charles M Rudin Chad M Vanderbilt

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

Read mapping to potential intratumoral Escherichia was associated with survival to single-agent ICI in two independent cohorts of patients with NSCLC.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
small cell lung cancer
free survival
high resolution
high density
risk assessment